JY
CLPT icon

Jeff Yass’s ClearPoint Neuro CLPT Stock Holding History

Jeff Yass’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.41M Buy
135,200
+10,900
+9% +$136K ﹤0.01% 6061
2026
Q1 		$1.13M Buy
124,300
+33,600
+37% +$424K ﹤0.01% 7559
2025
Q4 		$1.24M Buy
90,700
+31,500
+53% +$584K ﹤0.01% 6679
2025
Q3 		$1.29M Buy
59,200
+48,400
+448% +$570K ﹤0.01% 6728
2025
Q2 		$129K Buy
+10,800
New +$136K ﹤0.01% 11615
2025
Q1 		– Sell
-11,600
Closed -$178K – 12575
2024
Q4 		$178K Sell
11,600
-19,000
-62% -$246K ﹤0.01% 10848
2024
Q3 		$343K Buy
30,600
+11,200
+58% +$107K ﹤0.01% 9309
2024
Q2 		$105K Sell
19,400
-6,600
-25% -$38.2K ﹤0.01% 11001
2024
Q1 		$177K Buy
+26,000
New +$182K ﹤0.01% 10734
2022
Q4 		– Sell
-29,600
Closed -$307K – 12535
2022
Q3 		$307K Buy
+29,600
New +$390K ﹤0.01% 9737
2022
Q2 		– Sell
-16,600
Closed -$173K – 12989
2022
Q1 		$173K Buy
16,600
+3,900
+31% +$35.5K ﹤0.01% 11411
2021
Q4 		$142K Sell
12,700
-34,300
-73% -$513K ﹤0.01% 11852
2021
Q3 		$834K Buy
47,000
+5,600
+14% +$105K ﹤0.01% 8025
2021
Q2 		$790K Buy
+41,400
New +$800K ﹤0.01% 8410

Other funds holding CLPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
CFM
Compass Financial Management Tampa, Florida $829M AUM

Jeff Yass's CLPT Position: Q2 2026 in Review

Jeff Yass increased its ClearPoint Neuro (CLPT) stake by 76% in Q2 2026, buying an estimated $1.3M and bringing the position to 240,282 shares worth $4.29M. The position accounts for ﹤0.01% of the portfolio, ranked #4929.

Jeff Yass first reported a position in CLPT in Q1 2021 and has held it in 19 quarters since. The position peaked at $7.83M in Q4 2024. 129 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

  • Jeff Yass held 240,282 shares of ClearPoint Neuro worth $4.29M as of Q2 2026.
  • Jeff Yass bought 103,998 ClearPoint Neuro shares in Q2 2026, an estimated $1.3M.
  • ClearPoint Neuro made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #4929 holding.
  • Jeff Yass first reported a position in ClearPoint Neuro in Q1 2021 and has held it in 19 quarters since.
  • Jeff Yass's ClearPoint Neuro position peaked at $7.83M in Q4 2024.
  • 129 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.